Transcode Therapeutics Inc (RNAZ)

NASDAQ
2.82
+0.19(+7.22%)
After Hours
2.64
-0.18(-6.38%)
- Real-time Data
  • Volume:
    29,762
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    2.55 - 2.83

RNAZ Overview

Prev. Close
2.63
Day's Range
2.55-2.83
Revenue
-
Open
2.64
52 wk Range
2.35-7
EPS
-
Volume
29,762
Market Cap
36.34M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
3,852,294
P/E Ratio
-
Beta
-
1-Year Change
-
Shares Outstanding
12,885,645
Next Earnings Date
-
What is your sentiment on Transcode Therapeutics Inc?
or
Market is currently closed. Voting is open during market hours.

Transcode Therapeutics Inc Company Profile

Employees
4

TransCode Therapeutics, Inc., a biopharmaceutical company, engages in the development and commercialization of drugs for the treatment of metastatic diseases. The company’s lead therapeutic candidate, TTX-MC138, is a preclinical stage product for the treatment of metastatic cancer. Its products in discovery and preclinical stage include MicroRNA-10b, TTX-siPDL1, TTX-siLIN28b, and TTX-RIGA, which focuses on treating various cancers. The company was incorporated in 2016 and is based in Boston, Massachusetts.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyBuySell
Technical IndicatorsStrong BuyStrong BuyStrong BuySellBuy
SummaryStrong BuyStrong BuyStrong BuyNeutralNeutral
  • IPO was supposed to be yesterday. No sign yet. Why?
    0
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.